Home LiteratureArticle Details
PMID: 10922042 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.

Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ

Abstract

Strains of uropathogenic Escherichia coli (UPEC) are the causative agents in the vast majority of all urinary tract infections. Upon entering the urinary tract, UPEC strains face a formidable array of host defenses, including the flow of urine and a panoply of antimicrobial factors. To gain an initial foothold within the bladder, most UPEC strains encode filamentous surface adhesive organelles called type 1 pili that can mediate bacterial attachment to, and invasion of, bladder epithelial cells. Invasion provides UPEC with a protective environment in which bacteria can either replicate or persist in a quiescent state. Infection with type 1-piliated E. coli can trigger a number of host responses, including cytokine production, inflammation, and the exfoliation of infected bladder epithelial cells. Despite numerous host defenses and even antibiotic treatments that can effectively sterilize the urine, recent studies demonstrate that uropathogens can persist within the bladder tissue. These bacteria may serve as a reservoir for recurrent infections, a common problem affecting millions each year.

MeSH Terms
Animals Bacterial Adhesion Cytokines/physiology Escherichia coli/pathogenicity,physiology Escherichia coli Infections/immunology,microbiology Mice Mice, Inbred C57BL Microscopy, Electron Neutrophils/cytology Urinary Bladder/immunology,microbiology,ultrastructure Urinary Tract Infections/immunology,microbiology
Chemicals
Cytokines
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Mulvey M A
Department of Molecular Microbiology and Microbial Pathogenesis, Box 8230, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. mulvey@borcim.wustl.edu
Schilling J D
Martinez J J
Hultgren S J
References (45)
45 references, click to expand
  1. The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis.
    J Med Microbiol. 1990 Jun;32(2):135-41 PMID: 2192064
  2. Neutrophil recruitment and resistance to urinary tract infection.
    J Infect Dis. 1999 Oct;180(4):1220-9 PMID: 10479151
  3. Virulence factors in Escherichia coli urinary tract infection.
    Clin Microbiol Rev. 1991 Jan;4(1):80-128 PMID: 1672263
  4. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro.
    Infect Immun. 1992 Apr;60(4):1295-301 PMID: 1347759
  5. Lesions in two Escherichia coli type 1 pilus genes alter pilus number and length without affecting receptor binding.
    J Bacteriol. 1992 Sep;174(18):5923-35 PMID: 1355769
  6. Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli.
    J Biol Chem. 1993 Feb 5;268(4):3009-15 PMID: 8094080
  7. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.
    Antimicrob Agents Chemother. 2000 Jan;44(1):156-63 PMID: 10602738
  8. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.
    EMBO J. 2000 Jun 15;19(12):2803-12 PMID: 10856226
  9. The mammalian urinary bladder: an accommodating organ.
    Biol Rev Camb Philos Soc. 1975 May;50(2):215-46 PMID: 1100129
  10. An electron microscopic study of the interaction between vesical epitherlium and E. Coli.
    Invest Urol. 1979 Jul;17(1):61-8 PMID: 376485
  11. Bacteriology and ultrastructure of the bladder in patients with urinary tract infections.
    J Infect. 1985 Nov;11(3):191-9 PMID: 3936879
  12. Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells.
    Cell. 1987 Aug 28;50(5):769-78 PMID: 3304658
  13. Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism.
    Infect Immun. 1988 Jun;56(6):1615-7 PMID: 3286502
  14. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice.
    Infect Immun. 1984 Dec;46(3):839-44 PMID: 6389367
  15. Elevated interleukin-8 levels in the urine of patients with urinary tract infections.
    Infect Immun. 1993 Apr;61(4):1307-14 PMID: 8454332
  16. Interleukin-8 and the neutrophil response to mucosal gram-negative infection.
    J Clin Invest. 1993 Aug;92(2):780-5 PMID: 8349817
  17. Uroepithelial cells are part of a mucosal cytokine network.
    Infect Immun. 1994 Jun;62(6):2315-21 PMID: 8188354
  18. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae.
    Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2081-5 PMID: 7892228
  19. Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses.
    Ann N Y Acad Sci. 1995 Jul 21;762:308-18 PMID: 7545368
  20. Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule-1-dependent mechanism.
    Infect Immun. 1995 Oct;63(10):4054-62 PMID: 7558319
  21. A comparative study of the desquamation of urothelial cells during gestation and in adults mice following moderate stress or endotoxin treatment.
    Cell Biol Int. 1995 Nov;19(11):887-93 PMID: 8574215
  22. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells.
    Cell. 1996 Mar 22;84(6):923-32 PMID: 8601315
  23. Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli.
    J Exp Med. 1996 Mar 1;183(3):1037-44 PMID: 8642245
  24. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9630-5 PMID: 8790381
  25. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9827-32 PMID: 8790416
  26. Nonfimbrial adhesins of Escherichia coli.
    Adv Exp Med Biol. 1996;408:63-72 PMID: 8895778
  27. Formation of asymmetric unit membrane during urothelial differentiation.
    Mol Biol Rep. 1996;23(1):3-11 PMID: 8983014
  28. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.
    Immunity. 1997 Mar;6(3):315-25 PMID: 9075932
  29. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Science. 1997 Apr 25;276(5312):607-11 PMID: 9110982
  30. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    J Clin Invest. 1997 Sep 1;100(5):1123-36 PMID: 9276729
  31. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic.
    Nature. 1997 Oct 9;389(6651):636-9 PMID: 9335508
  32. Caspases: the executioners of apoptosis.
    Biochem J. 1997 Aug 15;326 ( Pt 1):1-16 PMID: 9337844
  33. Neutrophil receptors for interleukin-8 and related CXC chemokines.
    Semin Hematol. 1997 Oct;34(4):311-8 PMID: 9347581
  34. Bacterial virulence in urinary tract infection.
    Infect Dis Clin North Am. 1997 Sep;11(3):513-29 PMID: 9378921
  35. Pathogenesis of urinary tract infection. Role of host defenses.
    Infect Dis Clin North Am. 1997 Sep;11(3):531-49 PMID: 9378922
  36. Diagnosis and treatment of uncomplicated urinary tract infection.
    Infect Dis Clin North Am. 1997 Sep;11(3):551-81 PMID: 9378923
  37. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
    Infect Immun. 1998 Jun;66(6):2798-802 PMID: 9596750
  38. Clinical implications of mast cell-bacteria interaction.
    J Mol Med (Berl). 1998 Aug;76(9):617-23 PMID: 9725764
  39. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili.
    Mol Microbiol. 1998 Oct;30(2):285-93 PMID: 9791174
  40. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
    Science. 1998 Nov 20;282(5393):1494-7 PMID: 9822381
  41. Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection.
    J Infect Dis. 1999 Jan;179(1):172-9 PMID: 9841836
  42. Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract.
    J Immunol. 1999 Mar 1;162(5):3037-44 PMID: 10072556
  43. P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses.
    Mol Microbiol. 1999 Aug;33(4):693-703 PMID: 10447879
  44. X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli.
    Science. 1999 Aug 13;285(5430):1061-6 PMID: 10446051
  45. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria.
    Infect Immun. 1991 Jan;59(1):421-7 PMID: 1987054
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2000-08-01
Pages
8829-35
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC34019
Subset
IM
Grants
NIDDK NIH HHS · R01DK51406 · United States
NIAID NIH HHS · R01 AI029549 · United States
NIDDK NIH HHS · R01 DK051406 · United States
NIAID NIH HHS · F32 AI009787 · United States
NIAID NIH HHS · R01AI29549 · United States
NIAID NIH HHS · AI09787 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com